Incidence of zygomycosis in transplant recipients

Clinical Microbiology and Infection

Volumn 15, Issue SUPPL. 5, 2009, Pages 37-40

  Cuenca Estrella, M ^a   Bernal Martinez, L ^a   Isla, G ^a   Gomez Lopez, A ^a   Alcazar Fuoli, L ^a   Buitrago, M J ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Echinocandins; Emerging diseases; Invasive fungal infections; Mucorales; Voriconazole

Indexed keywords

VORICONAZOLE;

ASPERGILLOSIS; CANCER CHEMOTHERAPY; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG MYCOSIS; MUCORMYCOSIS; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; ZYGOMYCETES;

FUNGI; MUCORALES; ZYGOMYCETES;

COMMUNICABLE DISEASES, EMERGING; EUROPE; HUMANS; INCIDENCE; RISK FACTORS; TRANSPLANTATION; UNITED STATES; ZYGOMYCOSIS;

EID: 70349988092     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02978.x     Document Type: Review

References (38)

1. de Hoog GS, Guarro J, Gene J, Figueres MJ. Atlas of Clinical Fungi 2000, 81-123. 2nd edn, Utrecht, Reus, Centraalbureau voor Schimmelcultures, Universitat Rovira i Virgili, pp
2. Wingard JR. The changing face of invasive fungal infections in haematopoietic cell transplant recipients. Curr Opin Oncol 2005, 17:89-92.
3. Gomez-Lopez A, Cuenca-Estrella M, Mellado E, Rodriguez-Tudela JL. In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota. Diagn Microbiol Infect Dis 2003, 45:199-202.
4. Roden MM, Zaoutis TE, Buchanan WL. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005, 41:634-653.
5. Trifilio S, Singhal S, Williams S. Breakthrough fungal infections after allogeneic haematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2007, 40:451-456.
6. Kontoyiannis DP, Lionakis MS, Lewis RE. Zygomycosis in a tertiary care cancer centre in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005, 191:1350-1360.
7. Maertens J. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies. Eur J Haematol 2007, 78:275-282.
8. Husain S, Alexander BD, Munoz P. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003, 37:221-229.
9. Abbott KC, Hypolite I, Poropatich RK. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 2001, 3:203-211.
10. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mould infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001, 32:1319-1324.
11. Forrest GN, Mankes K. Outcomes of invasive zygomycosis infections in renal transplant recipients. Transpl Infect Dis 2007, 9:161-164.
12. Linden P, Williams P, Chan KM. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Clin Transplant 2000, 14(4 Pt 1):329-339.
13. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995, 20:617-620.
14. Zhang R, Zhang JW, Szerlip HM. Endocarditis and haemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis 2002, 40:842-846.
15. Gaziev D, Baronciani D, Galimberti M. Mucormycosis after bone marrow transplantation: report of four cases in thalassaemia and review of the literature. Bone Marrow Transplant 1996, 17:409-414.
16. Herbrecht R, Letscher-Bru V, Bowden RA. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001, 20:460-466.
17. Maertens J, Demuynck H, Verbeken EK. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999, 24:307-312.
18. Nosari A, Oreste P, Montillo M. Mucormycosis in haematologic malignancies: an emerging fungal infection. Haematologica 2000, 85:1068-1071.
19. Stelzmueller I, Lass-Floerl C, Geltner C. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int 2008, 21:534-546.
20. Kume H, Yamazaki T, Abe M, Tanuma H, Okudaira M, Okayasu I. Increase in aspergillosis and severe mycotic infection in patients with leukaemia and MDS: comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997. Pathol Int 2003, 53:744-750.
21. Nampoory MR, Khan ZU, Johny KV. Invasive fungal infections in renal transplant recipients. J Infect 1996, 33:95-101.
22. Severo LC, Oliveira FD, Dreher R, Teixeira PZ, Porto ND, Londero AT. Zygomycosis: a report of 11 cases and a review of the Brazilian literature. Rev Iberoam Micol 2002, 19:52-56.
23. Morduchowicz G, Pitlik SD, Shapira Z. Infections in renal transplant recipients in Israel. Isr J Med Sci 1985, 21:791-797.
24. Aslani J, Eizadi M, Kardavani B. Mucormycosis after kidney transplantations: report of seven cases. Scand J Infect Dis 2007, 39:703-706.
25. Diwakar A, Dewan RK, Chowdhary A, Randhawa HS, Khanna G, Gaur SN. Zygomycosis - a case report and overview of the disease in India. Mycoses 2007, 50:247-254.
26. Davari HR, Malekhossini SA, Salahi HA. Outcome of mucormycosis in liver transplantation: four cases and a review of literature. Exp Clin Transplant 2003, 1:147-152.
27. Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant centre and review of the literature. Am J Transplant 2006, 6:2365-2374.
28. Uckay I, Chalandon Y, Sartoretti P. Invasive zygomycosis in transplant recipients. Clin Transplant 2007, 21:577-582.
29. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004, 39:743-746.
30. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of haematopoietic stem cell transplants. N Engl J Med 2004, 350:950-952.
31. Siwek GT, Dodgson KJ, Magalhaes-Silverman M. Invasive zygomycosis in haematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004, 39:584-587.
32. Bakr A, Wafa E, Fouda A. Successful treatment of mucormycosis in a renal allograft recipient. Clin Exp Nephrol 2008, 12:207-210.
33. Clauss H, Samuel R. Simultaneous mould infections in an orthotopic heart transplant recipient. Transpl Infect Dis 2008, 10:343-345.
34. Eichna DM, Brown KS, Breen A, Dean RB. Mucormycosis: a rare but serious infection. Clin J Oncol Nurs 2008, 12:108-112.
35. Page AV, Evans AJ, Snell L, Liles WC. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis 2008, 10:419-425.
36. Upton A, Marr KA. Emergence of opportunistic mould infections in the haematopoietic stem cell transplant patient. Curr Infect Dis Rep 2006, 8:434-441.
37. Trifilio SM, Bennett CL, Yarnold PR. Breakthrough zygomycosis after voriconazole administration among patients with haematologic malignancies who receive haematopoietic stem cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007, 39:425-429.
38. Torres-Narbona M, Guinea J, Martinez-Alarcon J, Munoz P, Pelaez T, Bouza E. Workload and clinical significance of the isolation of Zygomycetes in a tertiary general hospital. Med Mycol 2008, 46:225-230.